⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27599816 | 0.97 | — | — | |
| Benzene SCHEMBL28335997 | 0.91 | CES1 (0.37) | — | |
| SCHEMBL21339899 | 0.75 | — | — | |
| SCHEMBL7516120 | 0.75 | — | — | |
| SCHEMBL27623481 | 0.72 | CA2 (0.35) | — | |
| SCHEMBL52 | 0.72 | CA2 (0.35) | — | |
| SCHEMBL3500822 | 0.72 | CA2 (0.35) | — | |
| SCHEMBL24625927 | 0.71 | — | — | |
| SCHEMBL23591848 | 0.69 | ALDH1A1 (0.33) | — | |
| SCHEMBL3945657 | 0.69 | CA2 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109705124-A | A kind of labeled with radioactive fluorine Larotrectinib compound and preparation method thereof | 上海健康医学院 | 2019-05-03 | — | — | CN | claimed |
| CN-122070309-A | Composition, resin composition, film-forming composition for lithography, and resist film-forming composition | 三菱瓦斯化学株式会社 | 2026-05-19 | — | — | CN | disclosed |
| US-20250250216-A1 | CYCLIC COMPOUND HAVING IODINE ATOM | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2025-08-07 | — | — | US | disclosed |
| CN-120136703-A | Compound, polymer, composition for film formation, pattern formation method, method for forming insulating film, and method for producing compound | 三菱瓦斯化学株式会社 | 2025-06-13 | — | — | CN | disclosed |
| CN-120136704-A | Compound, polymer, composition for film formation, pattern formation method, method for forming insulating film, and method for producing compound | 三菱瓦斯化学株式会社 | 2025-06-13 | — | — | CN | disclosed |
| EP-4565323-A1 | AROMATIC COMPOUNDS FOR USE AS PROTEIN PHOSPHATASE 2A (PP2A) MODULATORS | Rappta Therapeutics Oy (FI) | 2025-06-11 | — | — | EP | disclosed |
| CN-114269739-B | 1,3, 4-Diazole derivatives as histone deacetylase inhibitors | 奎马特里克斯公司 | 2025-04-22 | — | — | CN | disclosed |
| WO-2025079631-A1 | COMPOSITION, RESIN COMPOSITION, COMPOSITION FOR FILM FORMATION, COMPOSITION FOR FORMING LITHOGRAPHIC FILM, AND COMPOSITION FOR FORMING RESIST FILM | 三菱瓦斯化学株式会社 | 2025-04-17 | — | — | WO | disclosed |
| WO-2025033019-A1 | COMPOUND, COMPOSITION, METHOD FOR EXPRESSING SENSITIZING EFFECT, AND PRODUCTION METHOD | 三菱瓦斯化学株式会社 | 2025-02-13 | — | — | WO | disclosed |
| US-12202823-B2 | 1,3,4-oxadiazole derivatives as histone deacetylase inhibitors | QUIMATRYX, S.L. (ES) | 2025-01-21 | — | — | US | disclosed |
| CN-1135333-A | Usage of SRCSH2 specific compound for treatment of bone absorption disease | SMITHKLINE BEECHAM CORP (US) | 1996-11-13 | — | — | CN | disclosed |
| EP-0728482-A2 | Use of hcp specific compounds to enhance erythropoiesis | SMITHKLINE BEECHAM CORPORATION (US) | 1996-08-28 | — | — | EP | disclosed |
| EP-0727211-A1 | Use of src SH2 specific compounds to treat a bone resorption disease | SMITHKLINE BEECHAM CORPORATION (US) | 1996-08-21 | — | — | EP | disclosed |
| WO-1996024343-A1 | USE OF LCK SH2 SPECIFIC COMPOUNDS TO TREAT AUTOIMMUNE DISEASES AND ALLOGRAFT REJECTION | SMITHKLINE BEECHAM CORPORATION (US) | 1996-08-15 | — | — | WO | disclosed |
| US-5061798-A | Intermediates in the formation of synthetic hormones, mimic effects of thyroid hormones; little or no effect on the heart | SMITH KLINE & FRENCH LABORATORIES, LTD. (GB) | 1991-10-29 | — | — | US | disclosed |
| EP-0188351-B1 | CHEMICAL COMPOUNDS | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1991-03-13 | — | — | EP | disclosed |
| US-4910305-A | Containing a protected 4-hydroxyphenyl | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1990-03-20 | — | — | US | disclosed |
| US-4826876-A | WITHOUT EFFECT ON HEART | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1989-05-02 | — | — | US | disclosed |
| US-4766121-A | NOT AFFECTING THE HEART | SMITH KLINE & FRENCH LABORATORIES LTD. (GB) | 1988-08-23 | — | — | US | disclosed |
| EP-0188351-A2 | Chemical compounds | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1986-07-23 | — | — | EP | disclosed |